Ikeda Yoshitaka, Furumai Tamotsu, Igarashi Yasuhiro
Pharmaceuticals Research Unit, Mitsubishi Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan.
J Antibiot (Tokyo). 2005 Sep;58(9):566-72. doi: 10.1038/ja.2005.77.
In the screening for muscarinic M3 receptor binding inhibitors from microbial secondary metabolites, the extract of Nocardia nova JCM 6044 was found to be highly active. Bioassay-guided isolation led to the identification of three siderophores, nocardimicins G (1), H (2) and I (3). Their chemical structures were determined by spectroscopic analysis using NMR and MS. 1 and 2 inhibited the binding of tritium-labeled N-methylscopolamine to the muscarinic M3 receptor with Ki values of 0.44 microM and 0.37 microM, respectively, whereas 3 showed no inhibition at 10 microM. 1 and 2 also showed weak binding inhibitory activity to the M5 receptor but not to the M1, M2 and M4 receptors at 10 microM.
在从微生物次级代谢产物中筛选毒蕈碱M3受体结合抑制剂的过程中,发现新星诺卡氏菌JCM 6044的提取物具有高活性。通过生物活性导向分离鉴定出三种铁载体,即诺卡菌素G(1)、H(2)和I(3)。利用核磁共振(NMR)和质谱(MS)通过光谱分析确定了它们的化学结构。化合物1和2抑制氚标记的N-甲基东莨菪碱与毒蕈碱M3受体的结合,其抑制常数(Ki)值分别为0.44微摩尔和0.37微摩尔,而化合物3在10微摩尔浓度下未表现出抑制作用。在10微摩尔浓度下,化合物1和2对M5受体也表现出较弱的结合抑制活性,但对M1、M2和M4受体无抑制作用。